
Cedars-Sinai Cancer is seeking a nationally recognized, collaborative, and visionary investigator to serve as Program Leader for the Cancer Prevention and Control Program. This is a senior faculty leadership opportunity for an established scientist whose work advances cancer prevention and control across the cancer continuum, including cancer etiology, risk reduction, screening and early detection, behavioral interventions, health communication, implementation science, survivorship, cancer care delivery, and cancer health equity.
The Program Leader will shape the scientific agenda of the Cancer Prevention and Control Program, grow its peer-reviewed funding base, strengthen collaboration across Cedars-Sinai Cancer and partner institutions, and ensure that program science is responsive to the cancer burden and needs of the diverse communities Cedars-Sinai serves across Greater Los Angeles.
The Program Leader will provide scientific, strategic, and administrative leadership for an interdisciplinary research program. The successful candidate will maintain an outstanding independent research portfolio while catalyzing programmatic growth, mentoring faculty, building multi-investigator initiatives, and increasing the impact of Cedars-Sinai Cancer research in cancer prevention and control.
Provide strategic direction for the Cancer Prevention and Control Program.
Lead implementation of program goals, priorities, and metrics.
Maintain an outstanding, independent, cancer-relevant research program with sustained peer-reviewed extramural funding.
Mentor and support faculty, early-career investigators, trainees, and multidisciplinary teams.
Increase programmatic funding through multi-PI grants, program projects, and cross-program collaborations.
Convene and lead program meetings, working groups, retreats, and other activities that promote collaboration and scientific productivity.
Foster intra- and inter-programmatic collaborations across Cedars-Sinai Cancer, Cedars-Sinai departments and institutes, and external Cancer Centers.
Partner with Community Outreach and Engagement to develop research that addresses cancer burden in the Cedars-Sinai catchment area.
Review and report program metrics, including membership, grants, publications, shared resource use, clinical/population studies, collaborations, and impact.
Prepare annual program reports and materials for internal leadership, external advisory board review, and NCI Cancer Center Support Grant-style review activities.
Represent the program in institutional committees, strategic planning, philanthropy, education and training, community engagement, and external scientific forums.
Candidates may work in any area of cancer prevention and control. Areas of particular interest include, but are not limited to:
Cancer epidemiology, molecular epidemiology, genetic and environmental risk factors, exposomics, and risk prediction.
Screening, early detection, prevention trials, pragmatic trials, and implementation of evidence-based interventions.
Behavioral science, health communication, digital health, decision science, and intervention development.
Cancer health equity, social determinants of health, community-engaged research, and research addressing the Cedars-Sinai catchment area.
Lifestyle, obesity, physical activity, alcohol, tobacco, nutrition, metabolic health, and other modifiable cancer risk factors.
Cancer survivorship, symptom burden, quality of life, health services research, care delivery, and outcomes across the cancer continuum.
Population data science, real-world evidence, geospatial methods, electronic health record-based research, and learning health system approaches.
Cedars-Sinai Cancer is in a transformational period of growth and impact. Cedars-Sinai has been named to the U.S. News & World Report Best Hospitals Honor Roll for 10 consecutive years and tied for #1 in California and Los Angeles in the 2025-26 rankings. Cedars-Sinai is a major hub for biomedical research, with substantial extramural research funding and a rapidly expanding, vertically integrated health system. The cancer enterprise offers state-of-the-art treatments, experimental therapies, next-generation research, and cutting-edge clinical trials across more than 60 cancer types and more than 10 locations throughout Greater Los Angeles. Cedars-Sinai Cancer sees more than 10,300 new cancer cases each year, creating a rich environment for discovery, translational research, population science, and community-engaged cancer prevention and control.
The Cancer Prevention and Control Program at Cedars-Sinai Cancer is at an important stage of growth, creating a rare opportunity for a new Program Leader to help shape its scientific direction, priorities, collaborations, and long-term impact. The program focuses on collaborative, multifaceted research to reduce the current cancer burden and anticipate future cancer needs across Cedars-Sinai’s diverse catchment area and beyond. CPC emphasizes forward and reverse translation across the cancer continuum from community-engaged discovery to implementation, early detection, survivorship, and biologic insight, working closely with Community Outreach and Engagement, Cancer Therapeutics, Cancer Biology, and Cedars-Sinai’s shared research resources. Led by Jane Figueiredo, PhD, since 2024, the program currently includes 25 faculty members, including 9 full professors, 5 associate professors, and 11 assistant professors, and supports a strong research portfolio with $7.7 million in annual extramural, peer-reviewed cancer funding as of June 30, 2025. From January 2021 through June 2025, CPC members published 528 research publications, including 16% intra-programmatic, 25% inter-programmatic, and 49% inter-institutional collaborations with NCI-designated cancer centers; 16% appeared in journals with an impact factor greater than 10. The incoming leader will have substantial opportunity to influence the next phase of program development by strengthening team science, expanding externally funded research, mentoring faculty, building cross-programmatic initiatives, and advancing the program’s aims in cancer etiology, early detection and surveillance, prevention, and survivorship. This is an opportunity for an established investigator to help define a growing program’s identity and build a nationally recognized platform for population-centered cancer research.
Cedars-Sinai is committed to equitable healthcare, scientific excellence, and service to one of the most diverse regions in the nation. The Program Leader will be expected to foster research that reflects the needs of the Cedars-Sinai catchment area; advance inclusive, community-engaged approaches to cancer prevention and control; and mentor the next generation of investigators across backgrounds and disciplines.
Cedars-Sinai is an equal opportunity employer committed to building a workforce that reflects the diverse identities, experiences, and geographies of the communities and patients we serve. We encourage applications from candidates whose research, leadership, mentoring, and service advance equity, inclusion, and excellence in cancer prevention and control.
We offer competitive total compensation that includes pay, benefits, and other incentive programs for our employees.The base pay range shown takes into account the wide range of factors that are considered in making compensation decisions including knowledge/skills; relevant experience and training; education/certifications/licensure; and other business and organizational factors.This base pay range does not include our comprehensive benefits package and any incentive payments that may be applicable to this role.
*Pay range for physician scientists will consider medical subspecialty training.
Pay Range: $176,478 - $323,991
Doctoral degree or equivalent in a relevant discipline, such as PhD, ScD, DrPH, MD, MD/PhD, or equivalent training.
A nationally or internationally recognized research portfolio in cancer prevention and control or a closely related field.
Sustained record of peer-reviewed, cancer-relevant extramural funding as Principal Investigator or multi-PI.
High-impact publication record and demonstrated ability to lead innovative, collaborative research programs.
Experience mentoring junior faculty, trainees, and multidisciplinary research teams.
Demonstrated commitment to research that improves cancer prevention, control, equity, and outcomes for diverse populations.
Eligibility for appointment at the Associate Professor or Professor level, commensurate with experience and institutional criteria.
Experience leading an established cancer prevention, population science, public health, behavioral science, epidemiology, survivorship, or implementation science program.
Experience with NCI-designated cancer center research programs, external advisory boards or center-level strategic planning.
Record of building multi-investigator grants, center grants, cooperative agreements, clinical or community-based trials, or large data/resource platforms.
Strong record of collaboration across clinical, translational, population, community, and data science domains.
Applicants should submit the following materials:
Cover letter describing interest in the role and fit with Cedars-Sinai Cancer.
Curriculum vitae.
Research statement describing current and future scientific priorities.
Leadership statement describing vision for building a high-impact Cancer Prevention and Control Program.
Statement describing contributions to mentoring, inclusive excellence, community impact, and health equity.
Names and contact information for references.

Since its beginning in 1902, Cedars-Sinai has evolved to meet the healthcare needs of one of the most diverse regions in the nation, continually setting new standards for quality and innovation in patient care, research, teaching and community service.
Today, Cedars-Sinai is widely known for its national leadership in transforming healthcare for the benefit of patients.
Cedars-Sinai receives consistent recognition for our excellence. Our awards include; being named one of America’s Best Hospitals by U.S. News & World Report, receiving the National Research Corporation’s Consumer Choice Award 19 years in a row for providing the highest-quality medical care in Los Angeles, achieving the longest-running Magnet designation for nursing excellence in California, and being recognized as The Advisory Board Company’s 2017 Workplace of the Year, an award Cedars-Sinai has won three years in a row. This annual award recognizes hospitals and health systems nationwide that have outstanding levels of employee engagement.
Cedars-Sinai is a leader in the clinical care and research of heart disease, cancer and brain disorders, among other areas. Pioneering research achievements include using cardiac stem cells to repair damaged hearts, developing minimally invasive surgical techniques and discovering new types of drugs to target cancer more precisely.
Cedars-Sinai also impacts the future of healthcare through education programs that encompass everything from highly competitive medical residency and fellowship programs to a biomedical science and translational medicine PhD program, advanced training for nurses and educational opportunities for allied health professionals. Most notably, Cedars-Sinai demonstrates a longstanding commitment to strengthening the Los Angeles community through wide-ranging programs that improve the health of its most vulnerable residents.